New Insights into How Gut Microbes Trigger Immune Tolerance via Bacterial Sensor STING

Discover how the bacterial sensor protein STING plays a pivotal role in promoting immune tolerance to gut microbes, offering new insights into intestinal health and potential treatments for inflammatory bowel disease.
Recent research from Weill Cornell Medicine has uncovered a crucial mechanism behind immune tolerance to the vast community of microbes residing in the human gut. The study highlights the role of an ancient bacterial sensor protein known as STING, traditionally associated with promoting inflammation, in mediating immune tolerance within the gut lining. This discovery offers a fresh perspective on how the immune system distinguishes beneficial microbes from harmful pathogens.
The research focused on innate lymphoid cells, particularly ILC3s, which inhabit the mucosal lining of the intestines. Previously, it was established that these cells prevent immune attacks on gut bacteria, but the new findings reveal that their ability to do so heavily depends on STING signaling. Moderate activation of STING prompts ILC3s to induce immune tolerance, allowing beneficial microbes to coexist peacefully. Conversely, excessive STING activity can lead to the death of these cells, resulting in a breakdown of this tolerance and increased inflammation.
The team demonstrated that in mice, gut ILC3s sense bacteria through STING, which, despite its known pro-inflammatory role, in this context encourages immune cells to migrate to lymph nodes and promote regulatory T cells that dampen immune responses. When STING was deleted from ILC3s, mice showed heightened susceptibility to bacterial-induced gut inflammation. Interestingly, in inflammatory conditions such as inflammatory bowel disease (IBD), overactive STING signaling was observed, correlating with ILC3 depletion.
This research helps reconcile previous conflicting views on STING's role in gut health, suggesting that its impact depends on the level of activation. The findings open up potential therapeutic avenues, where modulating STING activity could restore tolerance and prevent or treat gut inflammation. Targeting this pathway may also help replace lost ILC3s, offering hope for novel treatments against inflammatory bowel diseases.
Overall, this study advances our understanding of the mammalian immune system’s adaptation to gut microbes and underscores the importance of balanced STING signaling in maintaining intestinal health.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Hospital-Based Program Boosts Hepatitis C Treatment for New Mothers
A novel hospital-based program significantly improves hepatitis C treatment completion for postpartum women by initiating therapy during hospital stay, reducing lost follow-up and increasing cure rates.
Decline in Measles Vaccination Rates Post-Pandemic Across U.S. Counties
Recent studies show a significant drop in measles vaccination rates across U.S. counties after the COVID-19 pandemic, heightening the risk of outbreaks. source: https://medicalxpress.com/news/2025-06-measles-vaccination-covid-pandemic-counties.html
WHO Approves Pandemic Agreement to Strengthen Global Health Response
The WHO committee approved a groundbreaking pandemic agreement aimed at improving global coordination, surveillance, and vaccine access to better prepare for future health emergencies.
Genetic Insights Reveal Chronic Pain and Mental Health as Modifiable Factors Increasing IBS Risk
Recent genetic research highlights chronic pain and mental health traits as key modifiable factors contributing to the development of irritable bowel syndrome (IBS). The study emphasizes the importance of addressing psychological and somatic health in IBS prevention.